Kala Pharmaceuticals Inc. (KALA)
Kala Pharmaceuticals Statistics
Share Statistics
Kala Pharmaceuticals has 6.09M shares outstanding. The number of shares has increased by 71.18% in one year.
| Shares Outstanding | 6.09M |
| Shares Change (YoY) | 71.18% |
| Shares Change (QoQ) | 0.06% |
| Owned by Institutions (%) | 0% |
| Shares Floating | 5.01M |
| Failed to Deliver (FTD) Shares | 6.87K |
| FTD / Avg. Volume | 11.31% |
Short Selling Information
The latest short interest is 37.47K, so 0.81% of the outstanding shares have been sold short.
| Short Interest | 37.47K |
| Short % of Shares Out | 0.81% |
| Short % of Float | 1.02% |
| Short Ratio (days to cover) | 1.91 |
Valuation Ratios
The PE ratio is -0.4 and the forward PE ratio is -1.46. Kala Pharmaceuticals's PEG ratio is 0.
| PE Ratio | -0.4 |
| Forward PE | -1.46 |
| PS Ratio | 0 |
| Forward PS | 1.5 |
| PB Ratio | 2.27 |
| P/FCF Ratio | -0.6 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Kala Pharmaceuticals Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.33, with a Debt / Equity ratio of 4.84.
| Current Ratio | 6.33 |
| Quick Ratio | 6.33 |
| Debt / Equity | 4.84 |
| Total Debt / Capitalization | 82.88 |
| Cash Flow / Debt | -0.77 |
| Interest Coverage | -6.73 |
Financial Efficiency
Return on equity (ROE) is -5.62% and return on capital (ROIC) is -89.34%.
| Return on Equity (ROE) | -5.62% |
| Return on Assets (ROA) | -0.75% |
| Return on Capital (ROIC) | -89.34% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-981,372.09 |
| Employee Count | 43 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -20.58% in the last 52 weeks. The beta is -2.2, so Kala Pharmaceuticals's price volatility has been lower than the market average.
| Beta | -2.2 |
| 52-Week Price Change | -20.58% |
| 50-Day Moving Average | 7.69 |
| 200-Day Moving Average | 6.65 |
| Relative Strength Index (RSI) | 38.66 |
| Average Volume (20 Days) | 60.74K |
Income Statement
| Revenue | n/a |
| Gross Profit | -303K |
| Operating Income | -39.15M |
| Net Income | -42.2M |
| EBITDA | -36.08M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -17.35 |
Balance Sheet
The company has 50.9M in cash and 36.32M in debt, giving a net cash position of 14.57M.
| Cash & Cash Equivalents | 50.9M |
| Total Debt | 36.32M |
| Net Cash | 14.57M |
| Retained Earnings | -629.41M |
| Total Assets | 54.08M |
| Working Capital | 27.41M |
Cash Flow
In the last 12 months, operating cash flow was -27.93M and capital expenditures -610K, giving a free cash flow of -28.54M.
| Operating Cash Flow | -27.93M |
| Capital Expenditures | -610K |
| Free Cash Flow | -28.54M |
| FCF Per Share | -11.73 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KALA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -274.09% |
| FCF Yield | -74.01% |
Analyst Forecast
The average price target for KALA is $15, which is 137% higher than the current price. The consensus rating is "Buy".
| Price Target | $15 |
| Price Target Difference | 137% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Oct 21, 2022. It was a backward split with a ratio of 1:50.
| Last Split Date | Oct 21, 2022 |
| Split Type | backward |
| Split Ratio | 1:50 |
Scores
| Altman Z-Score | -17.97 |
| Piotroski F-Score | 2 |